HAP Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $69.6K | Sell |
29,600
-1,200
| -4% | -$56K | ﹤0.01% | 559 |
|
|
2025
Q2 | $88.2K | Buy |
30,800
+17,200
| +126% | +$844K | 0.01% | 451 |
|
|
2025
Q1 | $14.7K | Sell |
13,600
-8,600
| -39% | -$501K | ﹤0.01% | 583 |
|
|
2024
Q4 | $21.4K | Sell |
22,200
-40,000
| -64% | -$2.23M | ﹤0.01% | 560 |
|
|
2024
Q3 | $140K | Buy |
62,200
+18,700
| +43% | +$877K | 0.02% | 357 |
|
|
2024
Q2 | $142K | Buy |
+43,500
| New | +$1.95M | 0.02% | 326 |
|
|
2023
Q4 | – | Sell |
-21,000
| Closed | -$51.4K | – | 970 |
|
|
2023
Q3 | $51.4K | Buy |
21,000
+10,200
| +94% | +$625K | 0.01% | 499 |
|
|
2023
Q2 | $24.2K | Sell |
10,800
-1,100
| -9% | -$73.8K | ﹤0.01% | 659 |
|
|
2023
Q1 | $30K | Sell |
11,900
-3,700
| -24% | -$261K | ﹤0.01% | 655 |
|
|
2022
Q4 | $34K | Sell |
15,600
-7,100
| -31% | -$535K | ﹤0.01% | 830 |
|
|
2022
Q3 | $50K | Buy |
22,700
+5,000
| +28% | +$363K | ﹤0.01% | 987 |
|
|
2022
Q2 | $30K | Sell |
17,700
-27,400
| -61% | -$2.09M | ﹤0.01% | 1218 |
|
|
2022
Q1 | $29K | Sell |
45,100
-2,100
| -4% | -$141K | ﹤0.01% | 1411 |
|
|
2021
Q4 | $47K | Buy |
47,200
+15,700
| +50% | +$921K | ﹤0.01% | 1509 |
|
|
2021
Q3 | $85K | Buy |
31,500
+2,300
| +8% | +$151K | ﹤0.01% | 1312 |
|
|
2021
Q2 | $27K | Sell |
29,200
-8,200
| -22% | -$535K | ﹤0.01% | 1712 |
|
|
2021
Q1 | $53K | Sell |
37,400
-13,300
| -26% | -$827K | ﹤0.01% | 1153 |
|
|
2020
Q4 | $52K | Sell |
50,700
-26,100
| -34% | -$1.6M | ﹤0.01% | 1390 |
|
|
2020
Q3 | $96K | Sell |
76,800
-423,000
| -85% | -$25.5M | ﹤0.01% | 803 |
|
|
2020
Q2 | $226K | Buy |
499,800
+420,500
| +530% | +$25.2M | 0.01% | 656 |
|
|
2020
Q1 | $234K | Buy |
+79,300
| New | +$4.85M | 0.02% | 511 |
|
|
2019
Q4 | – | Sell |
-86,500
| Closed | -$290K | – | 1247 |
|
|
2019
Q3 | $290K | Buy |
86,500
+12,600
| +17% | +$592K | 0.02% | 424 |
|
|
2019
Q2 | $524K | Sell |
73,900
-745,700
| -91% | -$34.7M | 0.04% | 328 |
|
|
2019
Q1 | $621K | Buy |
819,600
+555,400
| +210% | +$27.7M | 0.06% | 252 |
|
|
2018
Q4 | $403K | Buy |
264,200
+42,800
| +19% | +$2.3M | 0.03% | 400 |
|
|
2018
Q3 | $42K | Sell |
221,400
-5,000
| -2% | -$297K | ﹤0.01% | 648 |
|
|
2018
Q2 | $188K | Buy |
226,400
+11,700
| +5% | +$632K | 0.01% | 473 |
|
|
2018
Q1 | $184K | Sell |
214,700
-403,000
| -65% | -$25.9M | 0.01% | 464 |
|
|
2017
Q4 | $103K | Buy |
617,700
+562,200
| +1,013% | +$35.2M | ﹤0.01% | 576 |
|
|
2017
Q3 | $49K | Buy |
55,500
+26,800
| +93% | +$1.56M | ﹤0.01% | 656 |
|
|
2017
Q2 | $107K | Sell |
28,700
-640,600
| -96% | -$34.9M | 0.01% | 581 |
|
|
2017
Q1 | $1.74M | Sell |
669,300
-300,400
| -31% | -$16.5M | 0.11% | 153 |
|
|
2016
Q4 | $986K | Buy |
969,700
+316,900
| +49% | +$17.3M | 0.05% | 252 |
|
|
2016
Q3 | $1.78M | Buy |
652,800
+642,100
| +6,001% | +$41.2M | 0.06% | 166 |
|
|
2016
Q2 | $3K | Buy |
+10,700
| New | +$756K | ﹤0.01% | 859 |
|
|
2016
Q1 | – | Sell |
-18,100
| Closed | -$1K | – | 805 |
|
|
2015
Q4 | $1K | Sell |
18,100
-9,000
| -33% | -$595K | ﹤0.01% | 909 |
|
|
2015
Q3 | $30K | Buy |
27,100
+3,900
| +17% | +$247K | ﹤0.01% | 765 |
|
|
2015
Q2 | $16K | Sell |
23,200
-166,700
| -88% | -$11M | ﹤0.01% | 797 |
|
|
2015
Q1 | $380K | Buy |
189,900
+169,700
| +840% | +$10.6M | 0.03% | 372 |
|
|
2014
Q4 | $12K | Buy |
+20,200
| New | +$1.14M | ﹤0.01% | 890 |
|
|
2013
Q3 | – | Sell |
-679,000
| Closed | -$400K | – | 731 |
|
|
2013
Q2 | $400K | Buy |
+679,000
| New | +$29.5M | 0.01% | 540 |
|
Other funds holding BMY
HAP Trading's BMY Position: Q3 2024 in Review
HAP Trading sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 32,509 shares — an estimated $1.53M sold.
HAP Trading first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $288M in Q4 2019. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- HAP Trading reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
- HAP Trading sold 32,509 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.53M.
- HAP Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
- HAP Trading's Bristol-Myers Squibb position peaked at $288M in Q4 2019.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on HAP Trading's 13F filing for Q3 2024, filed 12 Nov 2024.